VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemesMarketEarningsCompareWatchlistInsider
SBRASabra Health Care REIT, Inc.
$18.12$4.6B
Research
Overview
Valuation
ValuationTargetsPrice
Financials
RevenueEarningsP/ERatiosDividend
Ownership
Holders
Tools
Total ReturnDCA Calculator
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

Follow VCP Scanner on XFollow VCP Scanner on LinkedIn
© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
  1. Home
  2. Financial Ratios

  1. Home
  2. SBRA
  3. Financial Ratios

Sabra Health Care REIT, Inc. (SBRA) Financial Ratios

16 years of historical data (2010–2025) · Real Estate · REIT - Healthcare Facilities

View Quarterly Ratios →

P/E Ratio
↓
28.31
↓-72% vs avg
5yr avg: 101.04
046%ile100
30Y Low10.6·High63.4
View P/E History →
EV/EBITDA
↑
15.63
+9% vs avg
5yr avg: 14.28
080%ile100
30Y Low9.1·High15.9
P/FCF
↑
13.11
+17% vs avg
5yr avg: 11.16
050%ile100
30Y Low6.5·High70.3
P/B Ratio
↑
1.57
↑+28% vs avg
5yr avg: 1.23
069%ile100
30Y Low0.6·High2.7
ROE
↑
5.6%
↓+472% vs avg
5yr avg: 1.0%
056%ile100
30Y Low-3%·High9%
Debt/EBITDA
↓
5.66
↓-5% vs avg
5yr avg: 5.95
033%ile100
30Y Low3.5·High8.8

Percentile shows where the current value sits in 30-year historical distribution. Sparklines show 5-year trend.

SBRA Valuation Multiples

Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow

Sabra Health Care REIT, Inc. trades at 28.3x earnings, 72% below its 5-year average of 101.0x, sitting at the 46th percentile of its historical range. Compared to the Real Estate sector median P/E of 24.1x, the stock trades at a premium of 18%. On a free-cash-flow basis, the stock trades at 13.1x P/FCF, 17% above the 5-year average of 11.2x.

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Market Cap$4.6B$4.6B$4.1B$3.3B$2.9B$3.0B$3.6B$4.0B$2.9B$2.0B$1.6B
Enterprise Value$7.0B$7.1B$6.5B$5.7B$5.4B$5.3B$6.0B$6.4B$6.1B$4.9B$2.8B
P/E Ratio →28.3129.5932.07241.46——25.9357.6810.5613.4126.54
P/S Ratio5.905.985.815.134.595.216.016.014.724.906.14
P/B Ratio1.571.641.491.190.940.881.061.150.900.581.58
P/FCF13.1113.2813.1711.059.099.1914.4410.786.52—9.05
P/OCF13.1113.2813.1711.059.098.3210.1510.788.2114.889.05

P/E links to full P/E history page with 30-year chart

SBRA EV Ratios

Enterprise-value multiples — capital-structure-neutral measures of total business value

Sabra Health Care REIT, Inc.'s enterprise value stands at 15.6x EBITDA, 9% above its 5-year average of 14.3x. The Real Estate sector median is 17.0x, placing the stock at a 8% discount on an enterprise-value basis.

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
EV / Revenue—9.189.208.858.609.309.969.659.8311.9910.69
EV / EBITDA15.6315.7715.1714.1512.7113.5914.339.109.9912.5410.97
EV / EBIT26.7126.3526.6444.49184.50—24.9018.6314.2719.6520.46
EV / FCF—20.3920.8419.0517.0116.4123.9317.3113.56—15.76

SBRA Profitability

Margins and return-on-capital ratios measuring operating efficiency

Sabra Health Care REIT, Inc. earns an operating margin of 34.1%, above the Real Estate sector average of 24.8%. ROE of 5.6% is modest. ROIC of 3.8% represents below-average returns on invested capital.

Margins

Full margin charts and quarterly trend are on the Earnings History page

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Gross Margin65.0%65.0%67.7%69.8%74.0%75.2%78.0%83.6%92.1%95.6%97.8%
Operating Margin34.1%34.1%36.5%34.2%37.6%37.0%—79.0%49.2%55.3%61.8%
Net Profit Margin20.1%20.1%18.0%2.1%-12.4%-19.9%23.1%10.3%44.8%39.0%27.0%

Return on Capital

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
ROE5.6%5.6%4.6%0.5%-2.4%-3.3%4.0%2.0%8.3%7.1%6.8%
ROA2.9%2.9%2.4%0.2%-1.3%-1.9%2.3%1.1%4.1%3.4%3.0%
ROIC3.8%3.8%3.7%3.1%3.1%2.8%—6.4%3.6%4.0%5.2%
ROCE5.2%5.2%5.0%4.2%4.2%3.6%—8.3%4.5%4.9%6.9%

SBRA Leverage & Debt

Solvency and debt-coverage ratios — lower is generally safer

Sabra Health Care REIT, Inc. carries a Debt/EBITDA ratio of 5.7x, which is highly leveraged (29% below the sector average of 7.9x). Net debt stands at $2.5B ($2.6B total debt minus $72M cash). Interest coverage of just 2.4x is concerning — the company has limited headroom to absorb earnings volatility before struggling with debt service.

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Debt / Equity0.900.900.890.870.830.720.710.710.990.991.19
Debt / EBITDA5.665.665.736.046.036.275.843.505.278.754.77
Net Debt / Equity—0.880.870.860.820.690.690.700.980.841.17
Net Debt / EBITDA5.505.505.595.945.915.985.683.435.197.424.67
Debt / FCF—7.117.688.007.927.239.496.537.04—6.70
Interest Coverage2.402.402.111.140.28-0.132.392.732.922.802.10

SBRA Liquidity & Efficiency

Short-term solvency ratios and asset-utilisation metrics

The current ratio of 0.56x is below 1.0, meaning current liabilities exceed current assets. The current ratio has declined from 0.78x to 0.56x over the past 3 years.

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Current Ratio0.560.560.880.780.591.78——3.128.024.66
Quick Ratio0.560.560.880.780.591.78——3.128.024.66
Cash Ratio0.210.210.270.180.150.78——0.535.060.65
Asset Turnover—0.140.130.120.110.100.100.110.090.060.11
Inventory Turnover———————————
Days Sales Outstanding———————————

SBRA Shareholder Yields

Earnings, FCF, buyback, and dividend yields — total returns to shareholders

Sabra Health Care REIT, Inc. returns 6.5% to shareholders annually primarily through dividends. The payout ratio exceeds 100% at 186.0%, meaning the company is paying out more than it earns — this level is unsustainable long-term without earnings recovery. The earnings yield of 3.5% (inverse of P/E) provides a useful comparison to bond yields when assessing the stock's relative attractiveness to fixed income.

Dividends

Full dividend history and growth charts are on the Dividend History page

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Dividend Yield6.5%6.3%6.9%8.4%9.7%8.9%7.7%8.4%11.0%9.2%7.5%
Payout Ratio186.0%186.0%221.1%2016.9%——201.1%486.2%116.5%115.0%169.7%

Total Shareholder Return Metrics

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Earnings Yield3.5%3.4%3.1%0.4%——3.9%1.7%9.5%7.5%3.8%
FCF Yield7.6%7.5%7.6%9.0%11.0%10.9%6.9%9.3%15.3%—11.0%
Buyback Yield0.0%0.0%0.0%0.1%0.2%0.0%0.0%0.0%4.9%0.0%0.0%
Total Shareholder Yield6.5%6.3%6.9%8.4%9.8%8.9%7.7%8.4%15.9%9.2%7.5%
Shares Outstanding—$244M$236M$233M$231M$219M$207M$188M$179M$106M$66M

Peer Comparison

Compare SBRA with 10 similar companies in its peer group

CompanyMarket CapP/EEV/EBITDAP/FCFGross MarginOp MarginROEROICDebt/EBITDA
SBRA logoSBRAYou$5B28.315.613.165.0%34.1%5.6%3.8%5.7
WELL logoWELL$145B148.764.650.839.2%3.3%2.5%0.5%8.6
VTR logoVTR$39B151.123.229.5-5.9%14.2%2.1%2.5%6.0
OHI logoOHI$13B23.016.315.144.5%62.6%11.6%6.0%4.0
LTC logoLTC$2B14.416.413.775.1%48.2%10.7%5.1%5.1
CTRE logoCTRE$9B23.622.923.159.1%67.2%9.2%6.1%2.2
NHI logoNHI$3B23.516.415.636.7%51.5%9.7%5.6%4.2
HR logoHR$7B-27.916.754.4-33.6%8.0%-4.9%0.7%6.3
DOC logoDOC$14B195.614.711.922.5%19.3%0.8%2.3%6.5
GMRE logoGMRE$94M115.38.3———-2.2%——
CHCT logoCHCT$498M225.216.28.88.7%16.7%1.1%1.6%8.4
Real Estate Median—24.117.015.449.3%24.8%3.7%2.7%7.9

Peer selection based on competitive and market overlap. Compare multiple stocks →

Download Financial Ratios Data

Includes 30+ ratios · 16 years · Updated daily

Consensus-Based Analysis Tools

Intrinsic Valuation

DCF models, multiple analysis, and analyst estimates.

Check Valuation

Historical Returns

10-year return with dividends reinvested.

Calculate

DCA Calculator

See how regular investing compounds over time.

Run Numbers

Peer Comparison

Compare growth, multiples, and margins vs sector.

Compare

SBRA — Frequently Asked Questions

Quick answers to the most common questions about buying SBRA stock.

What is Sabra Health Care REIT, Inc.'s P/E ratio?

Sabra Health Care REIT, Inc.'s current P/E ratio is 28.3x. The historical average is 32.7x. This places it at the 46th percentile of its historical range.

What is Sabra Health Care REIT, Inc.'s EV/EBITDA?

Sabra Health Care REIT, Inc.'s current EV/EBITDA is 15.6x. This enterprise value multiple compares the company's total value (equity + debt - cash) to its EBITDA. The historical average is 13.2x.

What is Sabra Health Care REIT, Inc.'s ROE?

Sabra Health Care REIT, Inc.'s return on equity (ROE) is 5.6%. The historical average is 4.5%.

Is SBRA stock overvalued?

Based on historical data, Sabra Health Care REIT, Inc. is trading at a P/E of 28.3x. This is at the 46th percentile of its historical P/E range. Compare with industry peers and growth rates for a complete picture.

What is Sabra Health Care REIT, Inc.'s dividend yield?

Sabra Health Care REIT, Inc.'s current dividend yield is 6.53% with a payout ratio of 186.0%.

What are Sabra Health Care REIT, Inc.'s profit margins?

Sabra Health Care REIT, Inc. has 65.0% gross margin and 34.1% operating margin. Operating margin above 20% indicates strong pricing power and cost efficiency.

How much debt does Sabra Health Care REIT, Inc. have?

Sabra Health Care REIT, Inc.'s Debt/EBITDA ratio is 5.7x, indicating high leverage. A ratio above 4x may signal elevated financial risk.